Apheresis Market Report
First published: 07 October 2024 | Last updated: 25 May 2026 | Report Code: apheresis
Apheresis Market — USD 2.5 billion in 2023, Growing to USD 4.91B by 2033 at 6.8% CAGR
This report provides comprehensive insights into the apheresis market from 2023 to 2033, including industry trends, market size, segmentation, and forecasts. It aims to equip stakeholders with the necessary data for informed decision-making.
Key Takeaways
- Global market rises from $2.50 Billion in 2023 to $4.91 Billion by 2033, reflecting a 6.8% CAGR across 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America is the largest region, growing from $0.82 Billion in 2023 to $1.61 Billion in 2033.
- Europe expands from $0.70 Billion to $1.38 Billion between 2023 and 2033; Asia Pacific moves from $0.49 Billion to $0.97 Billion.
- Top firms named include Fresenius Kabi, Terumo BCT, Haemonetics Corporation, and Cerus Corporation.
- Market momentum is supported by device innovation, rising therapeutic demand, and increased donor apheresis activity.
Apheresis Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The apheresis market is forecast to grow from $2.50 Billion in 2023 to $4.91 Billion by 2033 at a 6.8% CAGR during 2023 to 2033. Key drivers include advances in automated apheresis devices, rising therapeutic applications for autoimmune and chronic conditions, and increased awareness and use of donor apheresis. Regional growth patterns show North America as the largest market, moving from $0.82 Billion to $1.61 Billion over the decade. Europe, Asia Pacific, Latin America, and Middle East and Africa also register increases based on regional investment and healthcare adoption. Competitive dynamics feature established manufacturers such as Fresenius Kabi, Terumo BCT, Haemonetics Corporation, and Cerus Corporation focusing on product innovation and partnerships. Regulatory considerations and device maintenance remain factors to monitor, while ongoing R&D and clinical adoption are expected to sustain market expansion through 2033.
Key Growth Drivers
- Technological improvements in automated apheresis systems increasing procedural efficiency and throughput.
- Rising demand for therapeutic apheresis driven by greater diagnosis and treatment of autoimmune and chronic disorders.
- Expanded donor apheresis programs supporting blood component availability and transfusion services.
- Investment by major manufacturers into device innovation and consumable development enhancing treatment options.
- Healthcare infrastructure upgrades and clinician awareness promoting broader adoption across regions.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $4.91 Billion |
| Top Companies | Fresenius Kabi, Terumo BCT, Haemonetics Corporation, Cerus Corporation |
| Published Date | 07 October 2024 |
| Last Modified Date | 25 May 2026 |
Apheresis Market Overview
Customize Apheresis Market Report market research report
- ✔ Get in-depth analysis of Apheresis market size, growth, and forecasts.
- ✔ Understand Apheresis's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Apheresis
What is the Market Size & CAGR of Apheresis Market Report market in 2023?
Apheresis Industry Analysis
Apheresis Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Apheresis Market Report Market Analysis Report by Region
Europe Apheresis Market Report:
Europe grows from $0.7 Billion in 2023 to $1.38 Billion in 2033. 70 Billion in 2023 to $1.38 Billion by 2033. Growth drivers include increased clinical adoption of apheresis therapies, investments in hospital infrastructure, and regulatory pathways supporting device deployment and blood donation initiatives.Asia Pacific Apheresis Market Report:
Asia Pacific grows from $0.49 Billion in 2023 to $0.97 Billion in 2033. Regional momentum reflects rising healthcare investment, growing awareness of therapeutic apheresis, and expanding donor apheresis programs across key markets.North America Apheresis Market Report:
North America is largest regional market, rising from $0.82 Billion in 2023 to $1.61 Billion in 2033. Regional expansion is tied to established healthcare infrastructure, high adoption of advanced apheresis systems, and active clinical programs supporting both therapeutic and donor procedures.South America Apheresis Market Report:
Latin America grows from $0.13 Billion in 2023 to $0.26 Billion in 2033. Market movement is supported by gradual healthcare capacity building, increased availability of apheresis services, and efforts to scale blood collection and therapeutic procedures.Middle East & Africa Apheresis Market Report:
Middle East and Africa grows from $0.35 Billion in 2023 to $0.69 Billion in 2033. Growth is influenced by healthcare infrastructure enhancements, targeted investments in medical technologies, and expanded access to apheresis treatments and donor services.Tell us your focus area and get a customized research report.
Research Methodology
Apheresis Market Analysis By Product
In the product segment, blood collection sets dominate the market, valued at $1.61 billion in 2023, with a projection to reach $3.16 billion by 2033, accounting for around 64.22% market share. Apheresis devices will see significant growth from $0.52 billion in 2023 to $1.03 billion in 2033, holding 20.94% share, while consumables are expected to double to $0.73 billion by 2033.
Apheresis Market Analysis By Application
Therapeutic apheresis is the largest segment, estimated at $2.17 billion in 2023 and projected to grow to $4.27 billion by 2033, maintaining a dominant share of 86.96%. Donor apheresis accounts for a smaller share, forecasted to rise from $0.33 billion to $0.64 billion over the same period.
Apheresis Market Analysis By End User
Hospitals lead in end-user applications, currently valued at $1.61 billion in 2023 and expected to hit $3.16 billion by 2033. Blood banks and research centers, while smaller markets at $0.52 billion and $0.37 billion respectively in 2023, will also show promising growth.
Apheresis Market Analysis By Region
The regional analysis confirms North America as the largest market with ongoing innovations, followed by Europe and Asia-Pacific as rapidly growing regions due to improvements in healthcare and rising disease prevalence, while South America and the Middle East/Africa present emerging opportunities for market penetration.
Apheresis Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Apheresis Industry
Fresenius Kabi:
A leading provider of apheresis products and services, Fresenius Kabi focuses on innovative solutions for blood and cell therapy.Terumo BCT:
Terumo specializes in blood collection and processing systems, with a strong emphasis on apheresis technologies to enhance patient care.Haemonetics Corporation:
Identified as a global leader in blood management solutions, their advanced apheresis devices improve donor safety and therapeutic outcomes.Cerus Corporation:
Cerus is known for its innovative INTERCEPT Blood System, enhancing blood safety and optimizing apheresis procedures across the globe.We're grateful to work with incredible clients.
FAQs
What is the market size of the apheresis market in 2023?
The market size in 2023 is $2.50 Billion, as stated for the baseline year of the forecast period.
How big will the apheresis market be in 2033?
By 2033 the market is projected to reach $4.91 Billion according to the provided forecast figures.
What is CAGR for the forecast period?
The compound annual growth rate (CAGR) for 2023 to 2033 is 6.8% as indicated in the report data.
Is there a single fastest Growing region in the Apheresis Market Report market?
No single fastest-growing region is stated for the Apheresis Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies lead the apheresis sector?
Top companies listed include Fresenius Kabi, Terumo BCT, Haemonetics Corporation, and Cerus Corporation.
What are the primary drivers of market growth?
Primary drivers include device innovation, greater therapeutic demand, expanded donor programs, and increased clinical adoption.
Who contributed to the market research methodology?
The methodology includes primary interviews with industry experts, secondary research from company reports and publications, and data triangulation.
How is regional growth presented in the report?
Regional values are provided with start and end figures for 2023 and 2033, and the report names North America as the largest region; regional market region is Not specified.
What applications are covered in market segmentation?
Segmentation includes therapeutic apheresis and donor apheresis as the primary application categories.
Why is the fastest Growing region not named?
The regional growth market is Not specified because top regional growth rates are within 0.15 percentage points, preventing a single designation.